资讯
The Pancreatic Cancer Action Network (PanCAN) Executive Team is a group of dedicated professionals, some of whom have been personally touched by the disease, who bring significant experience and ...
Thanks to you and your continued advocacy, Congress is showing bipartisan recognition of the importance of investing in medical research. Last week, the House Labor-HHS subcommittee marked up its ...
Since 2003, we have awarded 236 grants to 217 scientists at 78 institutions and our total projected research investment is approximately $208 million, including our competitive Research Grants Program ...
Can Pancreatic Cancer Be Caught Early? Pancreatic cancer is hard to diagnose early. There is no standard diagnostic tool or established early detection method for pancreatic cancer in the general ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
Pancreatic tumors are either exocrine or neuroendocrine (endocrine) tumors. This is based on the type of cell they start in. Knowing the type of tumor is important because each type acts differently ...
Targeted therapy is cancer treatment that uses drugs to attack unique aspects of cancer cells with little harm to healthy cells. Targeted therapies often work by binding to a particular molecule in ...
PanCAN is leading large-scale, groundbreaking research initiatives that will be the catalyst for transforming the way pancreatic cancer is detected and treated. No single pancreatic cancer ...
Today, there is no screening test to detect pancreatic cancer early, when it’s more treatable. PanCAN is working to change that, thanks to donors like you. Earlier detection would mean that more ...
What are the symptoms of pancreatic cancer? Pancreatic cancer may cause only vague symptoms that could be confused with many other abdominal or gastrointestinal issues. It’s important to listen to ...
Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs) account for less than 10% of all pancreatic tumors. They may be benign or malignant and they tend to grow slower than exocrine tumors. They ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果